Zachary And Elizabeth M Fisher Center For Alzheimers Research Fdn
- Assets
- $30.2m
- Revenue
- $7.1m
- Investments
- $284.0k
- Employees
- 7
- Location
- New York, NY
- Founding
- 04/1996
- Data as of
- 12/2022
- EIN
- 13-3859563
Organization Overview
Zachary And Elizabeth M Fisher Center For Alzheimers Research Fdn, operating under the name Alzheimer's Research Foundationfisher Center, is located in New York, NY. The organization was established in 1996. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2022, Alzheimer's Research Foundationfisher Center employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alzheimer's Research Foundationfisher Center is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Alzheimer's Research Foundationfisher Center generated $7.1m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 6.8% each year. All expenses for the organization totaled $12.4m during the year ending 12/2022. While expenses have increased by 15.1% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Alzheimer's Research Foundationfisher Center has awarded 17 individual grants totaling $33,351,304. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO FUND RESEARCH INTO THE CAUSE, CARE, AND CURE OF ALZHEIMER'S DISEASE AT THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE AT THE ROCKEFELLER UNIVERSITY IN NEW YORK THAT WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
FISHER DRUG DISCOVERY RESOURCE CENTER:A GRANT WAS MADE TO THE ROCKEFELLER UNIVERSITY FOR THE FISHER DRUG DISCOVERY RESOURCE CENTER LOCATED AT THE ROCKEFELLER UNIVERSITY'S BRONK LABORATORY BUILDING TO HELP DRIVE TRANSFORMATIONAL SCIENCE AND FUEL THE DEVELOPMENT OF INNOVATIVE THERAPEUTICS WITH HIGH-THROUGHPUT AND SPECTROSCOPY RESOURCE CENTER (HTSRC). HIGH-THROUGHPUT SCREENING AND OTHER TECHNOLOGIES ENABLE THE IDENTIFICATION OF THERAPEUTIC TARGETS FOR POTENTIAL PREVENTIONS OR EFFECTIVE TREATMENTS OF VIRTUALLY ANY HUMAN DISEASE.
THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE (THE FISHER CENTER LAB):THE PRINCIPAL ACTIVITY OF THE FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION IS TO PROVIDE FUNDING TO THE FISHER CENTER LAB AT THE ROCKEFELLER UNIVERSITY, ONE OF THE LARGEST AND MOST MODERN FACILITIES IN THE WORLD DEDICATED TO SOLVING THE PUZZLE OF ALZHEIMER'S DISEASE. CURRENTLY LED BY NEWLY APPOINTED DIRECTOR, DR. NATHANIEL HEINTZ, THE JAMES AND MARILYN SIMONS PROFESSOR AT THE ROCKEFELLER UNIVERSITY. THE FISHER CENTER HAS PROVIDED RESEARCHERS AROUND THE GLOBE WITH A CONCEPTUAL FRAMEWORK FOR UNDERSTANDING THE DISEASE PROCESS AND CONTINUES TO BE AT THE FOREFRONT OF ONE DAY FINDING A CURE FOR ALZHEIMER'S DISEASE (AD).
4C. CASANOVA SARS-COV-2 INFECTION:A GRANT WAS MADE TO DR. CASANOVA'S RESEARCH ON UNDERSTANDING THE LIFE-THREATENING MANIFESTATION OF SARS-COV-2 INFECTION. HIS LABORATORY DISCOVERED THE HUMAN DETERMINANTS OF LIFE-THREATENING COVID-19 PNEUMONIA IN AT LEAST 20% OF PATIENTS, WITH INBORN ERRORS OF AND AUTO-ANTIBODIES TO TYPE I INTERFERONS. SARS-COV-2 WILL CONTINUE TO INFECT UNVACCINATED INDIVIDUALS FOR THE FORESEEABLE FUTURE AND WILL INCREASINGLY INFECT VACCINATED INDIVIDUALS AS IMMUNITY WANES OR AS VIRAL VARIANTS APPEAR THAT EVADE EXISTING VACCINE TARGETS. THE EMERGENCE OF VIRAL VARIANTS WITH GREATER FITNESS/TRANSMISSIBILITY AND IMMUNE EVASION POTENTIAL EXACERBATES THE THREAT TO HUMAN HEALTH, AS TRAGICALLY ILLUSTRATED WITH LIFE-THREATENING "BREAKTHROUGH CASES". THEIR APPROACH IS TO COUNTERATTACK THE VIRAL CHALLENGE USING SYNERGISTIC GENOMIC AND IMMUNOLOGIC APPROACHES. THEIR STUDIES INCLUDE DEEP ANALYSIS OF INTER-INDIVIDUAL GENETIC VARIABILITY, BUILDING ON DISCOVERY OF GERMLINE HUMAN GENETIC VARIANTS AND THEIR AUTOIMMUNE PHENOCOPIES PREDISPOSING TO POOR OUTCOME.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Barry R Sloane Chairman/treasurer | OfficerTrustee | 5 | $0 |
Martin Edelman Vice Chairman | OfficerTrustee | 0.75 | $0 |
David Hw Turner Secret Ary (thru Dec 2022), Vice Chairman | OfficerTrustee | 0.75 | $0 |
Hadley M Fisher Trustee (thru Dec 2022), Secretary | OfficerTrustee | 0.75 | $0 |
Dr Manny Alvarez Trustee | Trustee | 0.75 | $0 |
Gerry Byrne Trustee | Trustee | 0.5 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Core Staffing Services Inc Temporary Staffing | 12/30/22 | $365,240 |
The Staywell Company Llc Publishing Services | 12/30/22 | $263,853 |
Elite Accounting Services Llc Bookkeeping Services | 12/30/22 | $114,187 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $180,304 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $7,204,379 |
| Noncash contributions included in lines 1a–1f | $139,917 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $7,384,683 |
| Total Program Service Revenue | $1,215 |
| Investment income | $497,623 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$799,513 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $7,084,008 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $10,072,943 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $50,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $314,438 |
| Compensation of current officers, directors, key employees. | $62,888 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $505,406 |
| Pension plan accruals and contributions | $21,989 |
| Other employee benefits | $25,072 |
| Payroll taxes | $54,661 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $34,381 |
| Fees for services: Accounting | $150,539 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $172,538 |
| Fees for services: Other | $279,916 |
| Advertising and promotion | $155,575 |
| Office expenses | $80,921 |
| Information technology | $36,292 |
| Royalties | $0 |
| Occupancy | $16,246 |
| Travel | $6,617 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $4,402 |
| Insurance | $17,768 |
| All other expenses | $0 |
| Total functional expenses | $12,434,383 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,553,764 |
| Savings and temporary cash investments | $2,191,200 |
| Pledges and grants receivable | $958,539 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $5,154 |
| Prepaid expenses and deferred charges | $40,759 |
| Net Land, buildings, and equipment | $20,143 |
| Investments—publicly traded securities | $24,089,136 |
| Investments—other securities | $283,958 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $53,615 |
| Total assets | $30,196,268 |
| Accounts payable and accrued expenses | $156,698 |
| Grants payable | $9,565,217 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $9,721,915 |
| Net assets without donor restrictions | $20,294,049 |
| Net assets with donor restrictions | $180,304 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $30,196,268 |
Grants Awarded
Over the last fiscal year, Zachary And Elizabeth M Fisher Center For Alzheimers Research Fdn has awarded $10,062,943 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
THE ROCKEFELLER UNIVERSITY PURPOSE: TO FUND ALZHEIMER'S DISEASE RESEARCH. SEE PART IV FOR DETAILS. | $9,762,943 |
NEW YORK UNIVERSITY PURPOSE: TO FUND ALZHEIMER'S DISEASE RESEARCH. | $300,000 |